An injectable antibody given once every three months could effectively protect individuals from HIV infection.
ProAgio, a non-toxic protein, is being developed to inhibit the abnormal expression of a protein that is linked to cancer cells.
It's no cure, but virtual reality is giving us a new way to treat a host of conditions.
We can actually watch and see if chemotherapy is working against cancer cells.
Over 200,000 people subscribe to our newsletter.
Sign in to join the conversation.